Abstract
To validate a next-generation sequencing (NGS)-based companion diagnostic using the MiSeqDx® sequencing instrument to simultaneously detect 56 RAS mutations in DNA extracted from formalin-fixed paraffin-embedded metastatic colorectal cancer (mCRC) tumor samples from the PRIME study. The test's ability to identify patients with mCRC likely to benefit from panitumumab treatment was assessed. Samples from PRIME, which compared first-line panitumumab + FOLFOX4 with FOLFOX4, were processed according to predefined criteria using a multiplex assay that included input DNA qualification, library preparation, sequencing, and the bioinformatics reporting pipeline. NGS mutational analysis of KRAS and NRAS exons 2, 3, and 4 was performed and compared with Sanger sequencing. In 441 samples, positive percent agreement of the Extended RAS Panel with Sanger sequencing was 98.7% and negative percent agreement was 97.6%. For clinical validation (n = 528), progression-free survival (PFS) and overall survival (OS) were compared between patients with RAS mutations (RAS Positive) and those without (RAS Negative). Panitumumab + FOLFOX4 improved PFS in RAS Negative patients (P = 0.02). Quantitative interaction testing indicated the treatment effect (me...Continue Reading
References
Mar 5, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rafael G AmadoDavid D Chang
Oct 11, 2008·Nature Biotechnology·Jay Shendure, Hanlee Ji
May 1, 2010·The Journal of Molecular Diagnostics : JMD·Athanasios C TsiatisKathleen M Murphy
Oct 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Yves DouillardJennifer Gansert
Feb 10, 2011·Genes, Chromosomes & Cancer·Cecily P VaughnWade S Samowitz
Jan 18, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marc PeetersScott D Patterson
Sep 5, 2013·Therapeutic Advances in Gastroenterology·Sing Yu MoorcraftDavid Cunningham
Sep 13, 2013·The New England Journal of Medicine·Jean-Yves DouillardScott D Patterson
Mar 29, 2014·Acta Oncologica·Christina TherkildsenMef Nilbert
Apr 2, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lee S SchwartzbergWilliam Y Go
Aug 15, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M J SorichC S Karapetis
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemFortunato Ciardiello
May 6, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C BokemeyerS Tejpar
Jul 30, 2015·Genome Medicine·Jeffrey Gagan, Eliezer M Van Allen
Sep 6, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marc PeetersScott D Patterson
Oct 7, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carmen J AllegraRichard L Schilsky
Jul 7, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Van CutsemD Arnold
Feb 12, 2017·The Journal of Molecular Diagnostics : JMD·Antonia R SepulvedaJan A Nowak
Feb 12, 2017·The Journal of Molecular Diagnostics : JMD·Chih-Jian LihP Mickey Williams
Jan 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M J SorichC S Karapetis
Citations
Jul 28, 2019·Cells·Silvia GalbiatiMarcella Chiari
Jul 16, 2020·Gastroenterology Report·Zi-Nan LiMin-Jie Wei
Jul 28, 2019·Drugs·Julien TaiebPierre Laurent-Puig
Apr 18, 2020·Asia-Pacific Journal of Clinical Oncology·David Shao-Peng TanWilliam Ying Khee Hwang
Dec 15, 2019·The Journal of Molecular Diagnostics : JMD·Nitin UdarKaren Gutekunst
Mar 20, 2021·Frontiers in Oncology·Gerardo RosatiAntonio Avallone
May 7, 2021·Der Pathologe·Michael HummelArndt Vogel
Jul 15, 2021·Der Pathologe·Michael HummelArndt Vogel
Jul 4, 2021·Cancer Research·Jintao GuoQiyuan Li